Attached files
file | filename |
---|---|
10-K - SEELOS THERAPEUTICS, INC. | v178249_10k.htm |
EX-21 - SEELOS THERAPEUTICS, INC. | v178249_ex21.htm |
EX-3.7 - SEELOS THERAPEUTICS, INC. | v178249_ex3-7.htm |
EX-3.6 - SEELOS THERAPEUTICS, INC. | v178249_ex3-6.htm |
EX-32.2 - SEELOS THERAPEUTICS, INC. | v178249_ex32-2.htm |
EX-32.1 - SEELOS THERAPEUTICS, INC. | v178249_ex32-1.htm |
EX-31.1 - SEELOS THERAPEUTICS, INC. | v178249_ex31-1.htm |
EX-31.2 - SEELOS THERAPEUTICS, INC. | v178249_ex31-2.htm |
EX-10.48 - SEELOS THERAPEUTICS, INC. | v178249_ex10-48.htm |
EX-10.43 - SEELOS THERAPEUTICS, INC. | v178249_ex10-43.htm |
EX-10.44 - SEELOS THERAPEUTICS, INC. | v178249_ex10-44.htm |
EX-10.46 - SEELOS THERAPEUTICS, INC. | v178249_ex10-46.htm |
EX-10.42 - SEELOS THERAPEUTICS, INC. | v178249_ex10-42.htm |
EX-10.47 - SEELOS THERAPEUTICS, INC. | v178249_ex10-47.htm |
EX-10.45 - SEELOS THERAPEUTICS, INC. | v178249_ex10-45.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Stockholders
NexMed,
Inc.:
We
consent to the incorporation by reference in the Registration Statements on
Forms S-3 (Nos. 333-148060, 333-107137, 333-122114, 333-117717,
333-125565, 333-140110, 333-152591, 333-132611, 333-111894,
333-1055509, 333-96813, 333-46976, and 333-91957) and Form S-8 (Nos. 333-152284,
333-138598, and 333-93435) of our report dated March 31, 2010, with respect to
the consolidated financial statements, schedule, of NexMed, Inc. and
Subsidiaries included in the Annual Report on Form 10-K for the year ended
December 31, 2009. Such report includes an uncertainty paragraph with
respect to the ability of Nexmed, Inc. to continue as a going
concern.
/s/
Amper, Politziner & Mattia, LLP
Date:
March 31, 2010
Edison,
New Jersey